TY  - GEN
AU  - Reid,Tony
AU  - Oronsky,Bryan
AU  - Scicinski,Jan
AU  - Scribner,Curt L
AU  - Knox,Susan J
AU  - Ning,Shoucheng
AU  - Peehl,Donna M
AU  - Korn,Ron
AU  - Stirn,Meaghan
AU  - Carter,Corey A
AU  - Oronsky,Arnold
AU  - Taylor,Michael J
AU  - Fitch,William L
AU  - Cabrales,Pedro
AU  - Kim,Michelle M
AU  - Burris,Howard A
AU  - Lao,Christopher D
AU  - Abrouk,Nacer E D
AU  - Fanger,Gary R
AU  - Infante,Jeffrey R
TI  - Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study
SN  - 1474-5488
PY  - 2015///1214
KW  - Adult
KW  - Aged
KW  - Azetidines
KW  - administration & dosage
KW  - Dose-Response Relationship, Drug
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - pathology
KW  - Epigenesis, Genetic
KW  - drug effects
KW  - Female
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Nitro Compounds
KW  - Prognosis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S1470-2045(15)00089-3
ER  -